Physician profile
Alexander C Lemons
NPI 1699069211
$389,414.96
in general payments reported to CMS, 2019-2025
34 companies · $76K in 2025
The $76K reported for 2025 was more than what 91% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,019 · 2020: $7,153 · 2021: $16K · 2022: $49K · 2023: $74K · 2024: $158K · 2025: $76K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $196K · Travel and Lodging: $45K · Royalty Or License: $43K · Food and Beverage: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $196,011.65 |
| Travel and Lodging | $45,014.55 |
| Royalty Or License | $42,636.00 |
| Food and Beverage | $12,425.39 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,020.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Providence Medical Technology, INC. | $112,165.79 | 2020-2025 | |
| Spineart USA INC | $87,627.71 | 2019-2025 | Juliet Ll, Perla Tl, Perla C |
| Nexxt Spine LLC | $66,173.97 | 2019-2025 | Struxxure Mcs System, Convexx Cervical, Struxxure-L System |
| Life Spine, INC. | $38,140.19 | 2022-2025 | Arx, Modular Fixation System, Trulift Lateral |
| Arthrex, INC. | $33,790.38 | 2021-2024 | Arthrex |
| Medtronic, INC. | $23,499.73 | 2022-2025 | Midas Rex, Anatomic Peek Ptc Cervical Fusion System, Cd Horizon Spinal System |
| Royal Biologics, INC. | $9,600.00 | 2024-2025 | |
| Choice Spine, LLC | $4,990.84 | 2019-2021 | |
| Degen Medical, INC. | $2,225.00 | 2024-2025 | Cervical Am, Cervical Am |
| Abbott Laboratories | $1,870.18 | 2021-2024 | Proclaim, Eterna |
| Spineart Sa | $1,705.52 | 2022-2024 | |
| Tricoast Surgical Solutions LLC | $1,668.13 | 2022-2024 | |
| Spinal Elements, INC. | $1,210.67 | 2019-2025 | |
| Si-Bone, INC. | $986.96 | 2019-2025 | |
| Zimvie INC. | $748.54 | 2022-2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $615.52 | 2020-2024 | Senza |
| Southtech Orthopedics | $594.20 | 2021 | |
| Cerapedics INC. | $520.03 | 2020-2021 | |
| Innovation Technologies INC | $229.16 | 2022-2024 | Irrisept |
| Depuy Synthes Sales INC. | $167.91 | 2019 | |
| Stryker Corporation | $163.54 | 2019 | |
| Boston Scientific Corporation | $144.52 | 2023-2025 | Wavewriter Alpha Prime 16 |
| Medtronic USA, INC. | $116.57 | 2019 | |
| Zsfab, INC. | $103.66 | 2024 | |
| Intrinsic Therapeutics | $95.96 | 2023 | Barricaid Acd (Annular Closure Device) |
| Innovasis INC | $60.12 | 2021-2023 | |
| Globus Medical, INC. | $50.55 | 2025 | Senza, Vyrsa V1 |
| Baxter Healthcare | $36.31 | 2023-2024 | Floseal |
| Augmedics INC. | $32.98 | 2025 | Xvision |
| Kuros Biosciences USA, INC | $25.23 | 2022 | |
| Ethicon US, LLC | $16.18 | 2021 | |
| Arbor Pharmaceuticals, INC. | $13.32 | 2020 | |
| Pacira Therapeutics, INC. | $12.83 | 2019 | |
| Djo, LLC | $12.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Lemons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.